Drug-Induced Liver Injury.
Almario EE, Borlak J, Suzuki A, Chen M.
Biomed Res Int. 2017;2017:2461694. doi: 10.1155/2017/2461694. Epub 2017 Jan 9.
Sodium valproate-related hyperammonaemic encephalopathy.
Pegg EJ, Zaman F.
BMJ Case Rep. 2014 Apr 10;2014:bcr2014203899. doi: 10.1136/bcr-2014-203899.
Valproate-Associated Hyperammonaemic Encephalopathy.
Anthonipillai P, Sharp G, Kimber J, Ziauddin V.
Acute Med. 2022;21(1):43-46. doi: 10.52964/AMJA.0891.
Valproate poisoning.
Garnier R, Boudignat O, Fournier PE.
Lancet. 1982 Jul 10;2(8289):97. doi: 10.1016/s0140-6736(82)91713-5.
Hyperammonaemic encephalopathy.
Chetwood JD, Koorey D, Bryant C.
Intern Med J. 2022 Apr;52(4):693-694. doi: 10.1111/imj.15738.
Sodium valproate and the liver.
[No authors listed]
Lancet. 1980 Nov 22;2(8204):1119-20.
Toxin-induced hepatic injury.
Lopez AM, Hendrickson RG.
Emerg Med Clin North Am. 2014 Feb;32(1):103-25. doi: 10.1016/j.emc.2013.09.005.
Sodium valproate and routine liver function tests.
Green SH.
Arch Dis Child. 1984 Sep;59(9):813-4. doi: 10.1136/adc.59.9.813.
Melatonin ameliorates sodium valproate-induced hepatotoxicity in rats.
Oztopuz O, Turkon H, Buyuk B, Coskun O, Sehitoglu MH, Ovali MA, Uzun M.
Mol Biol Rep. 2020 Jan;47(1):317-325. doi: 10.1007/s11033-019-05134-6. Epub 2019 Oct 17.
Sulforaphane protects against sodium valproate-induced acute liver injury.
Nazmy EA, El-Khouly OA, Atef H, Said E.
Can J Physiol Pharmacol. 2017 Apr;95(4):420-426. doi: 10.1139/cjpp-2016-0447. Epub 2016 Nov 1.
